Divestment

Rainier Therapeutics

Rainier Therapeutics was a clinical-stage biotech developing targeted therapies for cancer.

Responsible partner
News

Key Facts

Sector: Life Sciences
Country: Netherlands
Fund: LSP 5
Entry: 2016
Exit: 2020

Responsible Partner

Fouad Azzam

Fouad Azzam

Partner

News

September 30, 2025
EQT Life Sciences portfolio company Merus to be acquired by Genmab in an all-cash USD 8.0 billion transaction
September 16, 2025
EQT Life Sciences portfolio company VarmX partners with CSL in a strategic collaboration and option agreement worth up to USD 2.2 billion
September 2, 2025
EQT Life Sciences Leads USD 44 Million Series B Financing in Cyted Health to Accelerate US Expansion
July 9, 2025
EQT Life Sciences leads USD 56 million Series D financing in Neuros Medical to commercialize FDA-approved treatment for post-amputation pain

Do You Want to Know More?

We are eager to explore how we can achieve great things together.

Rainier Therapeutics | EQT Portfolio